Table 2. Summary of cellular species, culture conditions, and observation setup used in the experiments in Figure 5.
| Species | Label | Strain | Medium | Temperature (°C) | Device | |
|---|---|---|---|---|---|---|
| E. coli | rpoS-mcherry glucose_30°C | MG1655 F3 rpoS-mcherry /pUA66-PrpsL-gfp | M9 minimal medium +0.2%(w/v) glucose +1/2 MEM amino acids solution (Sigma) | 30 | Microchamber array | This study |
| E. coli | rpoS-mcherry glucose_37°C | MG1655 F3 rpoS-mcherry /pUA66-PrpsL-gfp | M9 minimal medium +0.2%(w/v) glucose +1/2 MEM amino acids solution (Sigma) | 37 | Microchamber array | This study |
| E. coli | rpoS-mcherry glycerol_37°C | MG1655 F3 rpoS-mcherry /pUA66-PrpsL-gfp | M9 minimal medium +0.1%(v/v) glycerol +1/2 MEM amino acids solution (Sigma) | 37 | Microchamber array | This study |
| E. coli | f3nw -sm | F3NW | M9 minimal medium +0.2%(w/v) glucose +1/2 MEM amino acids solution (Sigma)+0.1mM Isopropyl β-D-1 thiogalactopyranoside (IPTG) | 37 | Agar pad | Nozoe et al., 2017 |
| E. coli | f3nw +sm | F3NW | M9 minimal medium +0.2%(w/v) glucose +1/2 MEM amino acids solution (Sigma)+0.1 mM Isopropylβ-D-1 thiogalactopyranoside (IPTG)+100 μg/ml streptomycin |
37 | Agar pad | Nozoe et al., 2017 |
| E. coli | f3ptn001 -sm | F3/pTN001 | M9 minimal medium +0.2%(w/v) glucose +1/2 MEM amino acids solution (Sigma)+0.1 mM Isopropylβ-D-1 thiogalactopyranoside (IPTG) | 37 | Agar pad | Nozoe et al., 2017 |
| E. coli | f3ptn001+sm | F3/pTN001 | M9 minimal medium +0.2%(w/v) glucose +1/2 MEM amino acids solution (Sigma)+0.1 mM Isopropylβ-D-1 thiogalactopyranoside (IPTG)+200 μg/ml streptomycin |
37 | Agar pad | Nozoe et al., 2017 |
| M. smegmatis | mc2155 7H9 | mc2155 | Middlebrook 7H9 medium +0.5% albumin +0.2% glucose +0.085% NaCl+0.5% glycerol +0.05% Tween-80 | 37 | Membrane cover | Wakamoto et al., 2013 |
| S. pombe | EMM28 | HN0025 | Edinburgh minimal medium +2% (w/v) glucose | 28 | Mother machine | Nakaoka and Wakamoto, 2017 |
| S. pombe | EMM30 | HN0025 | Edinburgh minimal medium +2%(w/v) glucose | 30 | Mother machine | Nakaoka and Wakamoto, 2017 |
| S. pombe | EMM32 | HN0025 | Edinburgh minimal medium +2%(w/v) glucose | 32 | Mother machine | Nakaoka and Wakamoto, 2017 |
| S. pombe | EMM34 | HN0025 | Edinburgh minimal medium +2%(w/v) glucose | 34 | Mother machine | Nakaoka and Wakamoto, 2017 |
| S. pombe | YE28 | HN0025 | Yeast extract medium +3%(w/v) glucose | 28 | Mother machine | Nakaoka and Wakamoto, 2017 |
| S. pombe | YE30 | HN0025 | Yeast extract medium +3%(w/v) glucose | 30 | Mother machine | Nakaoka and Wakamoto, 2017 |
| S. pombe | YE34 | HN0025 | Yeast extract medium +3%(w/v) glucose | 34 | Mother machine | Nakaoka and Wakamoto, 2017 |
| L1210 mouse leukemia cell | L1210 RPMI-1640 | L1210 (ATCC CCL-219) | RPMI-1640 medium (Wako)+10% fetal bovine serum (Biosera) under 5% CO2 atmosphere | 37 | Mother machine | Seita et al., 2021 |